
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The relative contributions of infectious and mitotic spread to HTLV-1 persistence
Daniel J. Laydon, Vikram Sunkara, Lies Boelen, et al.
PLoS Computational Biology (2020) Vol. 16, Iss. 9, pp. e1007470-e1007470
Open Access | Times Cited: 27
Daniel J. Laydon, Vikram Sunkara, Lies Boelen, et al.
PLoS Computational Biology (2020) Vol. 16, Iss. 9, pp. e1007470-e1007470
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread
С. В. Калиниченко, Dmitriy Komkov, Dmitriy Mazurov
Viruses (2022) Vol. 14, Iss. 1, pp. 152-152
Open Access | Times Cited: 41
С. В. Калиниченко, Dmitriy Komkov, Dmitriy Mazurov
Viruses (2022) Vol. 14, Iss. 1, pp. 152-152
Open Access | Times Cited: 41
Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia/lymphoma
Jun‐ichirou Yasunaga
International Journal of Hematology (2023) Vol. 117, Iss. 4, pp. 504-511
Open Access | Times Cited: 15
Jun‐ichirou Yasunaga
International Journal of Hematology (2023) Vol. 117, Iss. 4, pp. 504-511
Open Access | Times Cited: 15
Current Perspectives in Human T-Cell Leukemia Virus Type 1 Infection and Its Associated Diseases
Michi Miura, Tadasuke Naito, Mineki Saito
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 21
Michi Miura, Tadasuke Naito, Mineki Saito
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 21
Selective clonal persistence of human retroviruses in vivo: Radial chromatin organization, integration site, and host transcription
Anat Melamed, Tomas Fitzgerald, Yuchuan Wang, et al.
Science Advances (2022) Vol. 8, Iss. 17
Open Access | Times Cited: 19
Anat Melamed, Tomas Fitzgerald, Yuchuan Wang, et al.
Science Advances (2022) Vol. 8, Iss. 17
Open Access | Times Cited: 19
KIR-HLA interactions extend human CD8+ T cell lifespan in vivo
Yan Zhang, Ada W. C. Yan, Lies Boelen, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 11
Yan Zhang, Ada W. C. Yan, Lies Boelen, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 11
Precise excision of HTLV-1 provirus with a designer-recombinase
Teresa Rojo Romanos, Janet Karpinski, Sebastian Millen, et al.
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 2266-2285
Open Access | Times Cited: 10
Teresa Rojo Romanos, Janet Karpinski, Sebastian Millen, et al.
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 2266-2285
Open Access | Times Cited: 10
HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review
Daniel Bradshaw, Graham P. Taylor
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12
Daniel Bradshaw, Graham P. Taylor
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12
HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system
Benjy J.Y. Tan, Kenji Sugata, Masahiro Ono, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Benjy J.Y. Tan, Kenji Sugata, Masahiro Ono, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Identification and tracking of HTLV-1–infected T cell clones in virus-associated neurologic disease
Satoshi Nozuma, Eiji Matsuura, Masakazu Tanaka, et al.
JCI Insight (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 6
Satoshi Nozuma, Eiji Matsuura, Masakazu Tanaka, et al.
JCI Insight (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 6
Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets
Francesca Marino‐Merlo, Sandro Grelli, Antonio Mastino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14807-14807
Open Access | Times Cited: 6
Francesca Marino‐Merlo, Sandro Grelli, Antonio Mastino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14807-14807
Open Access | Times Cited: 6
Structural basis for the inhibition of HTLV-1 integration inferred from cryo-EM deltaretroviral intasome structures
M.S. Barski, Teresa Vanzo, Xue Zhi Zhao, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 13
M.S. Barski, Teresa Vanzo, Xue Zhi Zhao, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Cabotegravir, the Long-Acting Integrase Strand Transfer Inhibitor, Potently Inhibits Human T-Cell Lymphotropic Virus Type 1 Transmission in vitro
Bethany S. Schneiderman, M.S. Barski, Goedele N. Maertens
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Bethany S. Schneiderman, M.S. Barski, Goedele N. Maertens
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Human T-cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets
Francesca Marino‐Merlo, Sandro Grelli, Antonio Mastino, et al.
(2023)
Open Access | Times Cited: 3
Francesca Marino‐Merlo, Sandro Grelli, Antonio Mastino, et al.
(2023)
Open Access | Times Cited: 3
The impact of HTLV-1 expression on the 3D structure and expression of host chromatin
Hiroko Yaguchi, Anat Melamed, Saumya Ramanayake, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 3, pp. e1011716-e1011716
Open Access
Hiroko Yaguchi, Anat Melamed, Saumya Ramanayake, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 3, pp. e1011716-e1011716
Open Access
Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL)
Devon A Weterings, Aileen Rowan, Lucy Cook
Leukemia Research (2024) Vol. 148, pp. 107635-107635
Open Access
Devon A Weterings, Aileen Rowan, Lucy Cook
Leukemia Research (2024) Vol. 148, pp. 107635-107635
Open Access
Development of Potential Inhibitors for Human T-lymphotropic Virus Type I Integrase Enzyme: A Molecular Modeling Approach
Mohammad Jalili‐Nik, Arash Soltani, Seyed Isaac Hashemy, et al.
Current Computer - Aided Drug Design (2023) Vol. 20, Iss. 1, pp. 72-86
Closed Access | Times Cited: 1
Mohammad Jalili‐Nik, Arash Soltani, Seyed Isaac Hashemy, et al.
Current Computer - Aided Drug Design (2023) Vol. 20, Iss. 1, pp. 72-86
Closed Access | Times Cited: 1
Can Persistent Infections with Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, and Human T Lymphotropic Virus Type 1 Be Eradicated?
Sandy Vieira Teixeira, Gabriela Prates, Luiz Augusto Marcondes Fonseca, et al.
AIDS Research and Human Retroviruses (2023) Vol. 40, Iss. 3, pp. 127-133
Closed Access | Times Cited: 1
Sandy Vieira Teixeira, Gabriela Prates, Luiz Augusto Marcondes Fonseca, et al.
AIDS Research and Human Retroviruses (2023) Vol. 40, Iss. 3, pp. 127-133
Closed Access | Times Cited: 1
CRISPR Targeting the Integrated HTLV-1 Virus
Tasha Wilkie, Amanda R. Panfil
Springer eBooks (2022), pp. 127-144
Closed Access | Times Cited: 2
Tasha Wilkie, Amanda R. Panfil
Springer eBooks (2022), pp. 127-144
Closed Access | Times Cited: 2
Upregulation of Neuropilin-1 Inhibits HTLV-1 Infection
Wesley Kendle, Kimson Hoang, Erica Korleski, et al.
Pathogens (2023) Vol. 12, Iss. 6, pp. 831-831
Open Access
Wesley Kendle, Kimson Hoang, Erica Korleski, et al.
Pathogens (2023) Vol. 12, Iss. 6, pp. 831-831
Open Access
Targeted immunotherapy for HTLV-1-associated myelopathy: a step in the right direction
Nicholas Davies, Graham P. Taylor
Brain (2023) Vol. 146, Iss. 8, pp. 3114-3116
Open Access
Nicholas Davies, Graham P. Taylor
Brain (2023) Vol. 146, Iss. 8, pp. 3114-3116
Open Access
The impact of HTLV-1 expression on the 3D structure and expression of host chromatin
Hiroko Yaguchi, Anat Melamed, Saumya Ramanayake, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Hiroko Yaguchi, Anat Melamed, Saumya Ramanayake, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Human T‐Cell Lymphotropic Viruses
William M. Switzer, Walid Heneine, S. Michele Owen
ClinMicroNow (2023), pp. 1-15
Closed Access
William M. Switzer, Walid Heneine, S. Michele Owen
ClinMicroNow (2023), pp. 1-15
Closed Access
Human T‐Cell Lymphotropic Viruses
William M. Switzer, Walid Heneine, S. Michele Owen
ClinMicroNow (2023), pp. 1-15
Closed Access
William M. Switzer, Walid Heneine, S. Michele Owen
ClinMicroNow (2023), pp. 1-15
Closed Access
Rétrovirus humains T-lymphotropes
Karim Abdelmoumen, Chloé Journo
EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses (2023) Vol. 40, Iss. 4, pp. 1-14
Closed Access
Karim Abdelmoumen, Chloé Journo
EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses (2023) Vol. 40, Iss. 4, pp. 1-14
Closed Access
Retroviruses: Reversing the dogma of life - A review
Potlakayala Shobha, Miles Andrew, Patel Shrina, et al.
Journal of Clinical Microbiology and Biochemical Technology (2022) Vol. 8, Iss. 1, pp. 018-028
Open Access
Potlakayala Shobha, Miles Andrew, Patel Shrina, et al.
Journal of Clinical Microbiology and Biochemical Technology (2022) Vol. 8, Iss. 1, pp. 018-028
Open Access